HEREDITARY THROMBOPHILIAS AND THEIR INFLUENCE ON THE RISK OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION
Abstract
To evaluate the incidence of thrombophilia associated genes, 178 patients were examined using the mini-sequencing technique, with subsequent analysis of products using a mass spectrometer, in whom the medical history was collected, neurological assessment was performed, and, when deemed necessary, brain MRI were carried out.
About the Authors
M. Yu. Gilyarov
ГОУ ВПО Московская медицинская академия им. И. М. Сеченова
Russian Federation
Russian Federation
E. B. Generozov
ФГУ НИИ физико-химической медицины Росздрава
Russian Federation
Russian Federation
M. U. Magomadova
ГОУ ВПО Московская медицинская академия им. И. М. Сеченова
Russian Federation
Russian Federation
S. Yu. Moroshkina
ФГУ НИИ физико-химической медицины Росздрава
Russian Federation
Russian Federation
T. V. Pogoda
ФГУ НИИ физико-химической медицины Росздрава
Russian Federation
Russian Federation
P. A. Kostin
ГОУ ВПО Московская медицинская академия им. И. М. Сеченова
Russian Federation
Russian Federation
V. A. Sulimov
ГОУ ВПО Московская медицинская академия им. И. М. Сеченова
Russian Federation
Russian Federation
A. L. Syrkin
ГОУ ВПО Московская медицинская академия им. И. М. Сеченова
Russian Federation
Russian Federation
References
1. Баранова Е.И., Большакова О.О. Клиническое значение гомоцистеинемии (обзор литературы) // Consilium Medicum, 2001; 3: 133-137.
2. Зотова И.В. Предикторы образования тромба в левом предсердии у больных с персистирующей формой мерцательной аритмии. Автореф. дисс..канд. мед. наук. М., 2008.
3. Зотова И.В., Затейщиков Д.А., Сидоренко Б.А. Предикторы внутрисердечного тромбоза у больных с мерцательной аритмией: факторы гемостаза, маркеры воспалений и генетические факторы // Кардиология, 2007; 47: 46-54.
4. Калашникова Е.А., Кокаровцева С.Н., Коваленко Т.Ф. и др. Частоты мутаций в генах фактораV(FVLeiden), протромбина (G20210A) и 5,10-метилентетрагидрофолатредуктазы (C677T) у русских // Медицинская генетика, 2006; 7: 23-24.
5. Калашникова Л.А., Добрынина Л.А., Патрушева Н.Л. et al. Мутации генов, сочетающиеся с тромбозами, при ишемическом инсульте у больных с первичным антифосфолипидным синдромом // Тер. архив, 2005; 77: 49-53.
6. Козлова Т.В. Значимость генетических нарушений в системе гемокоагуляции и гипергомоцистеинемии как причинного фактора цереброваскулярных осложнений у больных с фибрилляцией предсердий // Неврологический вестник им. В.М.Бехтерева, 2005; 1-2: 35-40.
7. Никитина Л.А., Демидова Е.М., Садекова О.Н. и др. Роль некоторых генетических полиморфизмов в невынашивании беременности // Проблемы репродукции, 2007; 6: 83-89.
8. Сердечная Е.В. Фибрилляция предсердий: особенности клинического течения и выбор стратегии лечения. Автореф. дисс..докт. мед. наук. Архангельск, 2008.
9. Attia J., Thakkinstian A., Wang Y. et al. The PAI-1 4G/5G Gene Polymorphism and Ischemic Stroke: An Association Study and Meta-Analysis // Journal of Stroke & Cerebrovascular Diseases, 2007; 16: 173-179.
10. Casas J.P., Hingorani A.D., Bautista L. E. et al. Metaanalysis of Genetic Studies in Ischemic Stroke: Thirty-two Genes Involving Approximately 18 000 Cases and 58 000 Controls // Archives of Neurology, 2004; 61: 1652-1661.
11. Dahlback B. Advances in understanding pathogenic mechanisms of thrombophilic disorders // Blood, 2008; 112: 19-27.
12. Engbersen A.M., Franken D.G., Boers G.H. et al. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia // Am J Hum Genet, 1995; 56: 142-150.
13. Feinberg W.M., Macy E., Cornell E.S. et al. Plasmin-a2-antiplasmin Complex in Patients with Atrial Fibrillation // Thromb Haemost., 1999; 82: 100-103.
14. Flegel K.M., Shipley M.J., Rose G. Risk of stroke in non-rheumatic atrial fibrillation // Lancet, 1987; 329: 526-529.
15. Go A.S., Reed G.L., Hylek E.M. et al. Factor V Leiden and Risk of Ischemic Stroke in Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study // Journal of Thrombosis and Thrombolysis, 2003; 15: 41-46.
16. Gokce M., Ucar F., Kucukosmanoglu M. at al. Factor V Leiden Mutation and Its Relation to Left Atrial Thrombus in Chronic Nonrheumatic Atrial Fibrillation // Japanese Heart Journal, 2003; 44: 481-491.
17. Heppell R.M., Berkin K.E., McLenachan J.M. at al. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrilla tion // Heart, 1997; 77: 407-411.
18. Hughes M., Lip G.Y. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data // Throm. Haemost., 2008; 99: 295-304.
19. Kawamoto R., Kohara K., Oka Y. et al. An association of 5,10-Methylenetetrahydrofolate Reductase (MTH-FR) gene polymorphism and ischemic stroke // Journal of Stroke & Cerebrovascular Diseases, 2005; 14: 67-74.
20. Kucukarabaci B., Gunes H.V., Ozdemir G. et al. Investigation of Association between Plasminogen Activator Inhibitor Type-1 (PAI-1) Gene 4G/5G Polymorphism Frequency and Plasma PAI-1 Enzyme Activity in Patients with Acute Stroke // Genetic Testing, 2008; 12: 443-451.
21. Lakshminarayan K., Solid C. A., Collins A. J. et al. Atrial Fibrillation and Stroke in the General Medicare Population: A 10-Year Perspective (1992 to 2002) // Stroke, 2006; 37: 1969-1974.
22. Lip G.Y. The prothrombotic state in atrial fibrillation: New insights, more questions, and clear answers needed // American heart journal, 2000; 140: 348-350.
23. Marcucci R., Betti I., Cecchi E. et al. Hyperhomocysteinemia and vitamin B6 deficiency: New risk markers for nonvalvular atrial fibrillation? // American heart journal, 2004; 148: 456-461.
24. Marin F., Roldan V., Monmeneu J. et al. Prothrombotic state and elevated levels of plasminogen activator inhibitor-1 in mitral stenosis with and without atrial fibrillation // The American journal of cardiology, 1999; 84: 862-864.
25. Panigrahi I., Chatterjee T., Biswas A. et al. Role of MTHFR C677T polymorphism in ischemic stroke // Neurology India, 2006; 54: 48-50.
26. Poli D., Antonucci E., Cecchi E. et al. Thrombophilic mutations in high-risk atrial fibrillation patients: high prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism // Thromb Haemost, 2003; 90: 1158-1162.
27. Slavik L., Krcova V., Hlusi A. et al. Molecular pathophysiology of thrombotic states and their impact to laboratory diagnostics // Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2009; 153: 19-25.
28. Tsantes A.E., Nikolopoulos G.K., Bagos P.G. et al. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of ischemic stroke: a meta-analysis // Blood Coagulation & Fibrinolysis, 2007; 18: 497-504.
29. Varga E. Genetics in the context of thrombophilia // Journal of Thrombosis and Thrombolysis, 2008; 25: 2-5.
30. Wiklund P.G., Nilsson L., Ardnor S.N. et al. Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Risk of Stroke: Replicated Findings in Two Nested Case-Control Studies Based on Independent Cohorts // Stroke, 2005; 36: 1661-1665.
31. Xu X., Li J., Sheng W. at al. Meta-Analysis of Genetic Studies from Journals Published in China of Ischemic Stroke in the Han Chinese Population // Cerebrovascular Diseases, 2008; 26: 48-62.
Review
For citations:
Gilyarov M.Yu., Generozov E.B., Magomadova M.U., Moroshkina S.Yu., Pogoda T.V., Kostin P.A., Sulimov V.A., Syrkin A.L. HEREDITARY THROMBOPHILIAS AND THEIR INFLUENCE ON THE RISK OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION. Journal of Arrhythmology. 2009;(56):26-30. (In Russ.)
Views:
134
Email this article 